Denovo Biomarkers
Get Full AccessDescription
- A Novel Biomarker Discovery Solution for Personalized Drug Development Denovo Biopharma is a private San Diego based biotech company, also operating in China, providing a novel biomarker solution to personalize drug development. The core technology of the company is its industry's first platform and algorithm to perform de novo genomic biomarker discovery retrospectively using archived clinical samples. This technology is especially useful for late stage clinical drugs that have completed trials with unsatisfactory efficacy or side effect. By identifying biomarkers correlated to patients' responsiveness to drug candidates retrospectively, our technology enables biotech and pharmaceutical companies to design new clinical trials in targeted patient population to achieve higher efficacy and/or less adverse effects. Our platform can be broadly applied to biomarker discovery in most therapeutic areas, such as oncology and neurological diseases.
-
Headquarters:10240 Science Center Drive , San Diego, California, United States
More -
Phone Number:
-
Website: denovobiomarkers.com
-
Employees:24
-
Revenue:$10 - 50M
-
Legal Name:Denovo Biomarkers
-
Denovo Biomarkers's Social Media
-
Is this data correct?
-
| NAICS Code: 541713 |
Show More
Frequently Asked Questions regarding Denovo Biomarkers
-
Where are Denovo Biomarkers's Headquarters?
Denovo Biomarkers's Headquarters are in 10240 Science Center Drive ,San Diego,California,United States
-
What is Denovo Biomarkers's official website?
Denovo Biomarkers's official website is denovobiomarkers.com
-
What is Denovo Biomarkers's Revenue?
Denovo Biomarkers's revenue is $10 - 50M
-
What is Denovo Biomarkers's NAICS code?
Denovo Biomarkers's NAICS code is 541713
-
How many employees are working in Denovo Biomarkers
Denovo Biomarkers has 24 employees
-
What is Denovo Biomarkers's Industry?
Denovo Biomarkers is in the industry of Biotechnology
-
Who is Denovo Biomarkers's CEO?
Denovo Biomarkers's CEO is Wen Luo
-
Who is Denovo Biomarkers's Chief Financial Officer?
Denovo Biomarkers's Chief Financial Officer is Carrie

